Compared to normal colonic mucosa, PDE5 has a high expression in human CRC cell lines and in colon adenomas and adenocarcinomas (Lin et al., 2017), and PDE5 inhibition was found to have anti-tumor activity and potential in the inhibition of CRC (Yarla et al., 2019). This evidence concerns the gene PDE5A and neoplasm.